コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 arkers, and chemokines, most notably CX3CL1 (fractalkine).
2 x with the chemokine domain of human CX3CL1 (fractalkine).
3 d that TCR-driven TEM is also dependent upon fractalkine.
4 CXCR4 and CX3R1, the receptors for SDF-1 and fractalkine.
5 cells and differentiated osteoblasts express fractalkine.
6 kine receptor and modifies the activities of fractalkine.
7 mutants had a 100-fold decreased affinity to fractalkine.
8 lso showed a 100-fold decreased affinity for fractalkine.
9 GRO-alpha, -beta, and -gamma, and IL-8), and Fractalkine.
10 een these two functionally distinct forms of fractalkine.
11 IL-6 are able to increase the expression of fractalkine.
12 sponsible for the neuroprotective effects of fractalkine.
13 stinal epithelial cells as a novel source of fractalkine.
14 ould be illustrated by CX3CL1, also known as fractalkine.
15 ed that intra-PAG injection of 100 ng CX3CL1/fractalkine 30 min before administration of 400 ng DAMGO
16 ase (eNOS)], pro-inflammatory genes, CX3CL1 (fractalkine), 5-lipoxygenease-activating protein, and ma
19 ray on left ventricles (LV) showed increased fractalkine, a chemokine implicated in heart failure.
21 a at levels sufficient to drive induction of fractalkine, a key marker of inflammation in endothelial
22 a at levels sufficient to drive induction of fractalkine, a key marker of inflammation, in endothelia
25 igand 1), and the surface-attached chemokine fractalkine, all implicated in leukocyte trafficking, mi
29 phic effects of fractalkine, suggesting that fractalkine and its receptor are involved in a complex n
31 tigated the expression of the CX3C chemokine fractalkine and its receptor CX3CR1 in human coronary ar
32 VM) from male C57Bl/6 mice were treated with fractalkine and responses measured under basal condition
34 pplication of this methodology to the CX3CR1-fractalkine and the CXCR1-IL-8 receptor-ligand systems d
35 to determine the expression and function of fractalkine and the fractalkine receptor CX3CR1 in the h
36 cell damage and loss follow the induction of fractalkine and up-regulation of cell adhesion markers i
37 endothelial damage and apoptosis (release of fractalkine and von Willebrand factor; increased caspase
38 th inflammation, increased levels of CX3CL1 (fractalkine) and its unique receptor, CX3CR1, have been
39 communication between neurons (that produce fractalkine) and microglia (that express its receptor).
41 onclusion, our results indicate that CX3CR1, fractalkine, and the enzymes responsible for its cleavag
42 y reduced by a neutralizing antibody against fractalkine, and they migrate toward a medium conditione
45 ogether, these results suggest that IL-1 and fractalkine are endogenous regulators of morphine analge
47 M10/17) are involved in cleavage of neuronal fractalkine as indicated by studies with pharmacologic i
48 ing interleukin-1beta, interferon-gamma, and fractalkine as well as a decreased expression of synapto
50 tudies support a key regulatory role for the fractalkine axis in advanced and relapsed peritoneal met
51 ted the function of a potentially targetable fractalkine axis in the formation and the development of
53 By surface plasmon resonance measurements of fractalkine binding to biosensor chip-immobilized cell m
55 y protein-1beta), CCL5 (RANTES), and CX3CL1 (fractalkine), but not CXCL12 (stromal-derived factor-1al
56 CR1--the specific receptor for the chemokine fractalkine--by human prostate cancer cells, whereas hum
65 , we provide data showing that TACE-mediated fractalkine cleavage occurs at a site distinct from the
66 er, dihydrotestosterone was unable to induce fractalkine-cleavage from human bone marrow endothelial
68 vasation of CX3CR1-bearing cancer cells on a fractalkine concentration gradient, while leaving unalte
73 p-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis a
74 e receptor that uniquely binds to its ligand fractalkine (CX(3) CL1) and has been shown to be importa
80 s a specific receptor for the CX3C chemokine fractalkine (CX3CL1 according to the new chemokine nomen
86 y be exerting these effects via IL-1 because fractalkine (CX3CL1) induced the release of IL-1 from ac
93 avelled longer distance toward the source of fractalkine (CX3CL1), an endogenous ligand of CX3CR1.
94 yte chemoattractant protein-1 (MCP-1, CCL2), fractalkine (CX3CL1), or their cognate receptors, CCR2 a
95 transendothelial migration (TEM) depends on fractalkine (CX3CL1), PECAM-1 (CD31), and ICAM-1 (CD54)
96 or the 8-kDa chemokine binding domain of rat fractalkine (CX3CL1), the 18-kDa human hormone leptin, a
100 rprisingly, some markers of atherosclerosis (fractalkine/CX3CL1, CCL8, M-CSF, HGF), T-cell developmen
101 ults were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of
103 hese results indicate that the inhibition of fractalkine/CX3CR1 signaling in SGCs may serve as a targ
107 reduced dramatically by approximately 85% in fractalkine-deficient females [42,251 +/- 26,136 microm(
109 ls, aortic-root lesion area was unchanged in fractalkine-deficient male and female B6.ApoE(-/-) mice
110 n, the major reduction of atherosclerosis in fractalkine-deficient mice appears to be at the BCA rath
114 he immune environment at the injury site via fractalkine delivery resulted in a dramatic increase in
116 ion, dependence on ICAM-1, and dependence on fractalkine distinguish TCR-induced TEM from IP-10-induc
117 a positive correlation between the number of fractalkine-expressing cells and the number of CX3CR1-po
118 TNF-alpha provoked a significant increase in fractalkine expression and release of the soluble form,
119 ontrast to previous reports we do not detect fractalkine expression by Langerhans cells or immature d
121 histochemistry consistently showed increased fractalkine expression in placentas from severe early-on
122 -E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presenc
130 rophage response to chemoattractants such as fractalkine (FKN) (CX3CL1) and colony-stimulating factor
134 linked to the 8-kDa chemokine domain of rat fractalkine (FKN) for the purpose of surface exposure up
137 very of a cathepsin S (CatS) inhibitor and a fractalkine (FKN) neutralizing antibody, from day 11 to
140 sole member of the CX(3)C chemokine family, fractalkine (fkn), induces angiogenesis and that fkn mig
143 e chemoattractant protein 1 (MCP-1)/CCL2 and fractalkine (FKN)/CX3CL1 in cellular and mouse models of
149 nt transendothelial migration in response to fractalkine (FKN; FKN/CX3CL1) and stromal-derived factor
150 vated by the chemokine CX3CL1 (also known as fractalkine [FKN]), which promoted production of reactiv
151 r protease responsible for the conversion of fractalkine from a membrane-bound adhesion molecule to a
153 erone dramatically increases the cleavage of fractalkine from the plasma membrane of bone cells and i
156 , treatment with i.gl. fluorocitrate blocked fractalkine (i.gl.)- and carrageenin (paw)-induced hyper
158 tudied the influence of the chemokine CX3CL1/fractalkine in de novo breast cancer formation using HER
160 f mononuclear cells expresses high levels of fractalkine in human coronary atherosclerotic plaques an
161 cell type expressing transmembrane forms of fractalkine in human skin, the tonsil, and the large int
162 mechanisms regulating the levels of soluble fractalkine in the bone marrow, we focused on androgens,
164 as used to measure protein levels of soluble fractalkine in the medium of rat neuronal cultures expos
165 s [interleukin-1beta (IL-1)] and chemokines (fractalkine) in acute analgesia and in the development o
166 educing contractility after Iso stimulation, fractalkine increased the Ca(2+) transient amplitude but
168 incubation of isolated and cultured SGC with fractalkine induced the production/release of TNF-alpha,
170 ly, the activation of the CX3CR1 receptor by fractalkine induces the release of interleukin-1beta fro
171 helial cultures were monitored for levels of fractalkine induction as a marker for initiating the hos
172 endothelial monolayers is required for this fractalkine induction, where the endothelial cells appea
175 DAMs) 10 and 17, which convert transmembrane fractalkine into the soluble form, was significantly inc
185 uggest that, during peripheral inflammation, fractalkine is released in the DRG and contributes to th
186 We demonstrate that under normal conditions fractalkine is synthesized as an intracellular precursor
188 vascular cell adhesion molecule-1, IL-6, and fractalkine) is particularly high in malignant RCCs.
189 ty-prone mouse strain, the chemokine CX3CL1 (fractalkine) is rapidly induced in the neurons of the hy
190 cell response can result in the induction of fractalkine, leading to chronic inflammation and endothe
192 peptide 1-42 (Abeta(1-42)), Flt3 ligand, and fractalkine levels in CSF in a large cohort of PD patien
195 otactic protein-1, interleukin [IL]-8, IL-6, Fractalkine, macrophage inflammatory protein (MIP)-1beta
196 hemokine (SLC), EBI1-ligand chemokine (ELC), fractalkine, macrophage inflammatory protein-1gamma (MIP
201 of minocycline (inhibitor of microglia) and fractalkine (microglia-activating factor) on visceral hy
202 neuron-to-microglia signaling via chemokine fractalkine, microglia to astrocyte signaling via the cy
203 pression on endothelial cells, suggests that fractalkine might mediate adhesion of leukocytes to the
204 mino- or carboxyl-terminal ends of the human fractalkine molecule have revealed that epithelial cells
208 he reagent used in previous studies, an anti-fractalkine N-terminal peptide antisera, cross-reacts wi
209 of CC chemokines and a structure similar to fractalkine (neurotactin) in having a transmembrane regi
210 s such as fibroblast growth factor-4, CX3CL1/fractalkine, neurotrophin 4 oncostatin-M, pulmonary and
212 ts we do not detect high-level expression of fractalkine on endothelial cells in normal or inflamed c
214 on and platelet activation serum biomarkers (fractalkine, platelet P-selectin, platelet factor 4 [PF4
215 We have previously shown that the chemokine fractalkine promotes the adhesion of human prostate canc
216 of activation-associated chemokines such as fractalkine, RANTES (regulated on activation, normal T c
217 sults suggest that in human atherosclerosis, fractalkine, rather than mediating inflammatory cell rec
219 nced in mice lacking the microglial-specific fractalkine receptor (CX3CR1) and is dependent upon func
220 r mouse model studies support a role for the fractalkine receptor (CX3CR1) in the initiation of perit
221 shown that the deficiency of the microglial fractalkine receptor (CX3CR1) led to the acceleration of
224 ntrathecal neutralizing antibody against the fractalkine receptor (CX3CR1) potentiated acute morphine
227 the interaction between the chemokine CX3CL1/fractalkine receptor and mu, delta or kappa opioid recep
228 this study, we investigated the role of the fractalkine receptor chemokine CX3C motif receptor 1 (CX
229 ll subsets correlated with expression of the fractalkine receptor CX3CR1 (r2 = 0.99, P = 0.006).
230 al intraepithelial lymphocytes expressed the fractalkine receptor CX3CR1 and migrated specifically al
232 pression and function of fractalkine and the fractalkine receptor CX3CR1 in the human small intestina
233 vious studies have shown that the microglial fractalkine receptor CX3CR1 is involved in synaptic deve
234 lysosome content, but signaling through the fractalkine receptor CX3CR1 is not an essential componen
235 flammatory cells with high expression of the fractalkine receptor CX3CR1 that has been implicated in
236 hat a single chemokine receptor subtype, the fractalkine receptor CX3CR1, is able to reduce both infl
241 [chemokine receptor-2 knockout (CCR2(KO)) or fractalkine receptor knockout (CX3CR1(KO))] failed to re
242 nce, however, for an association between the fractalkine receptor polymorphism (CX3CR1-I249) and coro
243 vascular endothelium-homing receptor CX3CR1 (fractalkine receptor) are enriched in HIV-infected ART r
252 rols (WT) by ELISA and the effect of PGE2 on fractalkine secretion was measured in cultured neonatal
253 ipts, including CXCL1/KC, LCN2, iNOS, CX3CL1/fractalkine, SERPINA3G, and IkappaBalpha ("marker genes"
256 neural hearing loss by examining the role of fractalkine signaling after aminoglycoside ototoxicity o
257 and T280M, have been associated with reduced fractalkine signaling characterized by decreased adhesiv
261 s demonstrate that loss of neuron-microglial fractalkine signaling leads to reduced beta-amyloid depo
262 eukocytes into the spiral ganglion, and that fractalkine signaling plays a role in macrophage recruit
270 n the neuroprotective role of both SDF-1 and fractalkine, suggest that this novel interaction between
271 eceptors mediate the neurotrophic effects of fractalkine, suggesting that fractalkine and its recepto
273 rostatic interactions with basic residues on fractalkine that are necessary for receptor function but
274 he CX3CR1 receptor and undergo chemotaxis to fractalkine that can be inhibited by G protein inactivat
275 e phagocytic capability of microglia through fractalkine (the ligand of CX3CR1) signaling and by prom
278 This membrane-bound localization allows fractalkine to function as an adhesion molecule for cell
282 leukin-6, interleukin-8, interleukin-10, and fractalkine was identified to be the most important.
286 NF-alpha-mediated up-regulation of placental fractalkine was reversed in the presence of the aspirin-
287 leukin-6, interleukin-8, interleukin-10, and fractalkine, was significantly higher in patients who de
290 row aspirates express the cell-bound form of fractalkine, whereas the soluble form of the chemokine i
291 tivated by the neuronal chemokine CX3CL1 (or fractalkine) which controls key functions of microglial
292 y epithelial cells are a source of CX(3)CL1 (fractalkine), which mediates cell adhesion and acts as a
294 factors may be the proinflammatory chemokine fractalkine, which is expressed in the syncytiotrophobla
295 elopment, and the neuroprotective chemokine, fractalkine, which is upregulated during postnatal devel
296 en MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, f
297 late the expression and release of placental fractalkine, which, in turn, may contribute to an exagge
298 ymphotactin, and the murine CX(3)C chemokine fractalkine with high affinity (K(d) = 1.6 to 18.7 nM).
299 mutant receptors E13A, D16A, and D266A bound fractalkine with high affinity but were unable to induce
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。